Mutations in genes encoding GPCRs are observed in approximately 20% of cancers, including mutations in TSHR in thyroid cancer, luteinizing hormone receptor (LHCGR), and follicle stimulating hormone receptor (FSHR) in breast, lung, and colon cancers [127]. Here, FSHR is linked to cancer.